IQVIA Holdings Inc
$ 181.06
-0.61%
11 Jun - close price
- Market Cap 30,596,108,000 USD
- Current Price $ 181.06
- High / Low $ 182.05 / 178.02
- Stock P/E 22.77
- Book Value 37.27
- EPS 8.05
- Next Earning Report 2026-07-28
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.05 %
- ROE 0.22 %
- 52 Week High 247.05
- 52 Week Low 153.01
About
IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.
Analyst Target Price
$228.10
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-05-05 | 2026-02-05 | 2025-10-28 | 2025-07-22 | 2025-05-06 | 2025-02-06 | 2024-10-31 | 2024-07-22 | 2024-05-02 | 2024-02-14 | 2023-11-01 | 2023-08-01 |
| Reported EPS | 2.9 | 3.42 | 3 | 1.54 | 2.7 | 3.12 | 1.55 | 2.64 | 2.54 | 2.84 | 2.49 | 2.43 |
| Estimated EPS | 2.82 | 3.4 | 2.98 | 1.73 | 2.63 | 3.11 | 1.92 | 2.56 | 2.48 | 2.82 | 2.45 | 2.37 |
| Surprise | 0.08 | 0.02 | 0.02 | -0.19 | 0.07 | 0.01 | -0.37 | 0.08 | 0.06 | 0.02 | 0.04 | 0.06 |
| Surprise Percentage | 2.8369% | 0.5882% | 0.6711% | -10.9827% | 2.6616% | 0.3215% | -19.2708% | 3.125% | 2.4194% | 0.7092% | 1.6327% | 2.5316% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-07-28 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | 2.74 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: IQV
2026-06-12 11:53:51
IQVIA Holdings Inc., through its subsidiary IQVIA Inc., issued €950 million in 4.625% Senior Notes due 2034. These notes, detailed in an 8-K filing, aim to optimize the company's capital structure and potentially fund strategic initiatives. The offering includes provisions for redemption, an equity clawback, and change of control protection for bondholders.
2026-06-12 08:40:36
Thermo Fisher Scientific (TMO) stock has experienced a volatile year, with a 14.9% gain over the last year despite a 19.7% year-to-date drop. A Discounted Cash Flow (DCF) analysis suggests the stock is currently undervalued by 20.1% at its current share price of around $475, with an intrinsic value estimated at $595.47. Conversely, its Price vs. Earnings (P/E) ratio of 25.81x is very close to Simply Wall St’s Fair Ratio model of 25.62x, indicating it is appropriately priced based on earnings.
2026-06-12 00:05:11
IQVIA Holdings Inc. (IQV) has completed a €950 million senior notes offering due in 2033 with an interest rate of 4.625% per annum. The proceeds will be used to refinance existing debt and cover offering-related fees. This strategic financial move aims to optimize IQVIA's capital structure and enhance its financial flexibility.
2026-06-11 20:52:56
IQVIA has successfully raised €950 million through an offering of 4.625% senior notes due in 2033. These notes are intended to refinance existing debt and cover related fees. The unsecured notes will pay interest semi-annually and are redeemable with an equity claw provision prior to June 15, 2029.
2026-06-11 20:46:58
IQVIA Holdings Inc., through its wholly-owned subsidiary IQVIA Inc., has issued €950 million of 4.625% senior notes due 2033. These unsecured euro-denominated notes will mature on June 15, 2033, with semi-annual interest payments beginning on December 15, 2026. The net proceeds from this offering are intended to refinance existing indebtedness and cover related fees and expenses, replacing older debt with this new issue.
2026-06-10 16:57:00
IQVIA Holdings Inc. (IQV) shares fell by 2.19% to $182.17 on Wednesday, underperforming the broader market. This decline occurred during a negative trading session where the S&P 500 Index and Dow Jones Industrial Average also saw significant drops. The stock's fall ended a two-day winning streak.
